Detalles de la búsqueda
1.
Efficacy, safety, and pharmacokinetics by BMI category in Phase 3/3b cabotegravir + rilpivirine long-acting trials.
J Infect Dis
; 2023 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38134313
2.
Pregnancy outcomes and pharmacokinetics in pregnant women living with HIV exposed to long-acting cabotegravir and rilpivirine in clinical trials.
HIV Med
; 24(5): 568-579, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36411596
3.
A prospective patient registry to monitor safety, effectiveness, and utilisation of bedaquiline in patients with multidrug-resistant tuberculosis in South Korea.
BMC Infect Dis
; 23(1): 15, 2023 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36624432
4.
Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis.
BMC Infect Dis
; 22(1): 870, 2022 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36414938
5.
Cabotegravir + Rilpivirine Long-Acting: Overview of Injection Guidance, Injection Site Reactions, and Best Practices for Intramuscular Injection Administration.
Open Forum Infect Dis
; 11(6): ofae282, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38882931
6.
FluAlert: a qualitative evaluation of providers' desired characteristics and concerns regarding computerized influenza vaccination alerts.
Prev Med
; 52(3-4): 274-7, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21276811
7.
Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3 FLAIR study.
Lancet HIV
; 8(11): e668-e678, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34656207
8.
Folic Acid for the prevention of neural tube defects.
Am Fam Physician
; 82(12): 1533, 2010 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21166375
Resultados
1 -
8
de 8
1
Próxima >
>>